We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg PR Newswire LONDON, Jan. 14, 2025 LONDON, Jan. 14, 2025 /PRNewswire/...
Hikma Pharmaceuticals Plc 23 December 2024 Hikma Pharmaceuticals PLC (the "Company") LONDON, 23 December 2024: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) (LEI:...
Hikma Pharmaceuticals Plc 07 November 2024 Hikma Pharmaceuticals PLC Outcome of Audit Tender Process LONDON, 7 November 2024 - Hikma Pharmaceuticals PLC ('the Company' or 'Hikma...
Hikma Pharmaceuticals PLC on Thursday said it is on track to deliver "another strong performance" following trading t ...
Hikma Pharmaceuticals Plc 07 November 2024 Hikma continues strong strategic execution and reiterates guidance London, 7 November 2024 - Hikma Pharmaceuticals PLC (Hikma, Group), the...
Hikma Pharmaceuticals Plc 24 October 2024 Hikma Pharmaceuticals PLC 2024 Annual General Meeting Update Statement LONDON, 24 October 2024 - Hikma Pharmaceuticals PLC ('Hikma' or 'the...
Hikma Pharmaceuticals Plc 01 October 2024 Hikma Pharmaceuticals PLC Block Listing Six Monthly Return Date: 1 October 2024 Name of applicant: Hikma Pharmaceuticals PLC Name of scheme:...
Hikma Pharmaceuticals Plc 24 September 2024 Hikma Pharmaceuticals PLC (the "Company") LONDON, 24 September 2024: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) (LEI:...
Hikma Pharmaceuticals PLC announced on Tuesday it has completed its acquisition of the US finished dosage form busine ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 32 | 1.55793573515 | 2054 | 2102 | 1986 | 370260 | 2027.53145764 | DE |
4 | 154 | 7.97101449275 | 1932 | 2102 | 1919 | 334314 | 2006.32726137 | DE |
12 | 134 | 6.86475409836 | 1952 | 2102 | 1757 | 444572 | 1909.59837841 | DE |
26 | 232 | 12.5134843581 | 1854 | 2102 | 1757 | 384947 | 1925.86255582 | DE |
52 | 126 | 6.42857142857 | 1960 | 2165 | 1750 | 411302 | 1918.63820293 | DE |
156 | 9 | 0.433317284545 | 2077 | 2222 | 1174.5 | 566848 | 1781.20711612 | DE |
260 | 180.5 | 9.47257937549 | 1905.5 | 2766 | 1174.5 | 594928 | 2024.99406858 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions